-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Pro-Dex (NASDAQ:PDEX) Now Covered by StockNews.com
Pro-Dex (NASDAQ:PDEX) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report published on Tuesday. The firm issued a buy rating on the medical instruments supplier's stock.
Pro-Dex Stock Down 2.9 %
NASDAQ:PDEX opened at $16.89 on Tuesday. The company has a quick ratio of 1.39, a current ratio of 2.73 and a debt-to-equity ratio of 0.41. The stock's fifty day moving average is $16.98 and its two-hundred day moving average is $17.46. Pro-Dex has a 52 week low of $12.40 and a 52 week high of $26.50. The stock has a market capitalization of $60.47 million, a price-to-earnings ratio of 16.24 and a beta of 0.94.
Get Pro-Dex alerts:Pro-Dex (NASDAQ:PDEX – Get Rating) last posted its quarterly earnings data on Thursday, November 3rd. The medical instruments supplier reported $0.29 earnings per share for the quarter. Pro-Dex had a return on equity of 16.75% and a net margin of 8.97%. The business had revenue of $11.09 million for the quarter.
Hedge Funds Weigh In On Pro-Dex
Several large investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its stake in shares of Pro-Dex by 2.7% during the third quarter. Dimensional Fund Advisors LP now owns 58,126 shares of the medical instruments supplier's stock worth $1,030,000 after buying an additional 1,535 shares during the period. LSV Asset Management lifted its position in Pro-Dex by 13.9% in the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after purchasing an additional 4,346 shares during the period. JPMorgan Chase & Co. lifted its position in Pro-Dex by 59.2% in the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock valued at $345,000 after purchasing an additional 7,762 shares during the period. State Street Corp lifted its position in Pro-Dex by 5.8% in the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after purchasing an additional 650 shares during the period. Finally, Renaissance Technologies LLC acquired a new stake in Pro-Dex in the second quarter valued at about $168,000. Hedge funds and other institutional investors own 13.49% of the company's stock.About Pro-Dex
(Get Rating)
Pro-Dex, Inc engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches.
Featured Stories
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com承擔了對以下股票的報道Pro-Dex(納斯達克:PDEX-GET評級)在週二發佈的一份報告中。該公司對這家醫療器械供應商的股票發佈了買入評級。
Pro-Dex股價下跌2.9%
納斯達克:PDEX週二開盤報16.89美元。該公司的速動比率為1.39,流動比率為2.73,債務權益比率為0.41。該股的50日移動均線切入位為16.98美元,200日移動均線切入位為17.46美元。Pro-Dex的52周低點為12.40美元,52周高位為26.50美元。該股市值為6,047萬美元,本益比為16.24倍,貝塔係數為0.94。
到達支持Dex警報:Pro-Dex(納斯達克代碼:PDEX-GET Rating)最近一次公佈季度收益數據是在11月3日星期四。這家醫療器械供應商公佈了本季度每股收益0.29美元。Pro-Dex的股本回報率為16.75%,淨利潤率為8.97%。該業務本季度的收入為1109萬美元。
對沖基金對Pro-Dex的看法
幾家大型投資者最近買賣了該公司的股票。Dimension Fund Advisors LP在第三季度將其在Pro-Dex的股份增加了2.7%。Dimension Fund Advisors LP現在擁有這家醫療器械供應商的58,126股票,價值1,030,000美元,在此期間又購買了1,535股票。LSV Asset Management在第一季度將其在Pro-Dex的頭寸提高了13.9%。LSV資產管理公司現在擁有這家醫療器械供應商的35,581股股票,價值588,000美元,在此期間又購買了4,346股。今年第一季度,摩根大通將Pro-Dex的倉位提高了59.2%。摩根大通公司目前持有這家醫療器械供應商20,863股股票,價值345,000美元,在此期間又購買了7,762股。道富集團在第一季度將其在Pro-Dex的頭寸提高了5.8%。道富集團目前持有這家醫療器械供應商11,923股股票,價值19.7萬美元,在此期間又購買了650股。最後,復興科技有限責任公司在第二季度收購了Pro-Dex的新股份,價值約16.8萬美元。對沖基金和其他機構投資者持有該公司13.49%的股份。關於Pro-Dex
(獲取評級)
Pro-Dex,Inc.致力於設計、開發和製造旋轉驅動外科和牙科器械。該公司專門從事醫療設備和服務、工業和科學、牙科和零部件、維修和其他業務。其產品包括成品醫療器械、微型氣動馬達、牙科產品、塑料注射成型和扭矩扳手。
專題報道
- 免費獲取StockNews.com Pro-Dex上的研究報告(PDEX)
- 市場回顧周-1/23-1/27
- 為什麼Lucid在一天內飆升了近100%
- 利用這些鐵路股票實現增長和收入
- ASML預計今年晶片需求回升,提振銷售觀點
- KLA公司:在動盪不安的半市場中站穩腳跟
接受Pro-Dex Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pro-Dex和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧